Profiel
David R.
Seaton served as the Acting CEO, Chief Financial Officer & Secretary at MEI Pharma, Inc. from 2009 to 2010.
Prior to that, he was the Chief Financial Officer at Kazia Therapeutics Ltd.
from 1999 to 2010.
He also served as the Chief Financial Officer & Secretary at Glycotex, Inc. Mr. Seaton received his undergraduate and graduate degrees from The University of New South Wales.
Eerdere bekende functies van David R. Seaton
| Bedrijven | Functie | Einde |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Financieel Directeur/CFO | 18-06-2010 |
| MEI PHARMA, INC. | Financieel Directeur/CFO | 21-06-2010 |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Financieel Directeur/CFO | - |
Opleiding van David R. Seaton
| The University of New South Wales | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |
